Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 2
1969 1
1970 2
1971 1
1972 2
1973 1
1974 2
1976 1
1978 2
1979 2
1980 1
1982 4
1983 2
1984 2
1985 1
1986 2
1987 2
1988 3
1989 16
1990 22
1991 8
1992 24
1993 18
1994 20
1995 16
1996 16
1997 18
1998 19
1999 17
2000 20
2001 7
2002 8
2003 15
2004 19
2005 18
2006 26
2007 37
2008 52
2009 48
2010 44
2011 80
2012 67
2013 58
2014 66
2015 60
2016 66
2017 42
2018 55
2019 54
2020 66
2021 49
2022 42
2023 48
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

1,175 results

Results by year

Filters applied: . Clear all
Page 1
Early-life peripheral infections reprogram retinal microglia and aggravate neovascular age-related macular degeneration in later life.
Hata M, Hata M, Andriessen EM, Juneau R, Pilon F, Crespo-Garcia S, Diaz-Marin R, Guber V, Binet F, Fournier F, Buscarlet M, Grou C, Calderon V, Heckel E, Melichar HJ, Joyal JS, Wilson AM, Sapieha P. Hata M, et al. J Clin Invest. 2023 Feb 15;133(4):e159757. doi: 10.1172/JCI159757. J Clin Invest. 2023. PMID: 36787231 Free PMC article.
Choroideremia Gene Therapy.
Lam BL, Davis JL, Gregori NZ. Lam BL, et al. Int Ophthalmol Clin. 2021 Oct 1;61(4):185-193. doi: 10.1097/IIO.0000000000000385. Int Ophthalmol Clin. 2021. PMID: 34584056 Free PMC article. No abstract available.
Choroideremia.
Dimopoulos IS, Radziwon A, St Laurent CD, MacDonald IM. Dimopoulos IS, et al. Curr Opin Ophthalmol. 2017 Sep;28(5):410-415. doi: 10.1097/ICU.0000000000000392. Curr Opin Ophthalmol. 2017. PMID: 28520608 Review.
Choroideremia: molecular mechanisms and therapies.
Sarkar H, Moosajee M. Sarkar H, et al. Trends Mol Med. 2022 May;28(5):378-387. doi: 10.1016/j.molmed.2022.02.011. Epub 2022 Mar 24. Trends Mol Med. 2022. PMID: 35341685 Review.
Choroideremia: The Endpoint Endgame.
Abdalla Elsayed MEA, Taylor LJ, Josan AS, Fischer MD, MacLaren RE. Abdalla Elsayed MEA, et al. Int J Mol Sci. 2023 Sep 20;24(18):14354. doi: 10.3390/ijms241814354. Int J Mol Sci. 2023. PMID: 37762657 Free PMC article. Review.
Molecular Therapies for Choroideremia.
Cehajic Kapetanovic J, Barnard AR, MacLaren RE. Cehajic Kapetanovic J, et al. Genes (Basel). 2019 Sep 23;10(10):738. doi: 10.3390/genes10100738. Genes (Basel). 2019. PMID: 31548516 Free PMC article. Review.
Liver-directed gene therapy for ornithine aminotransferase deficiency.
Boffa I, Polishchuk E, De Stefano L, Dell'Aquila F, Nusco E, Marrocco E, Audano M, Pedretti S, Caterino M, Bellezza I, Ruoppolo M, Mitro N, Cellini B, Auricchio A, Brunetti-Pierri N. Boffa I, et al. EMBO Mol Med. 2023 Apr 11;15(4):e17033. doi: 10.15252/emmm.202217033. Epub 2023 Jan 17. EMBO Mol Med. 2023. PMID: 36647689 Free PMC article.
1,175 results